Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2026 ,inter alia, to consider and approve To consider and approve raising of funds through the issuance of Non-Convertible Debentures (NCDs) and/or such other securities as may be permitted under applicable laws, and to approve seeking shareholders'' approval, as may be required

October 7, 2026 BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers Exchange Plaza Dalal Street, Fort Bandra Kurla Complex, Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub: Intimation of Board Meeting – October 12, 2026 Ref: Prior Intimation of the Board Meeting pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of Jubilant Pharmova Limited is scheduled to be held on Monday, October 12, 2026, inter alia, to consider and approve raising of funds through the issuance of Non- Convertible Debentures (NCDs) and/or such other securities as may be permitted under applicable laws, and to approve seeking shareholders' approval, as may be required in this regard. The aforesaid information is also being made available on the website of the Company at www.jubilantpharmova.com. This is for your information and records. Thanking you, Yours faithfully, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary